BioNxt Solutions (OTCMKTS:BNXTF) Stock Jumps 23.1% – Should You Buy?

BioNxt Solutions Inc. (OTCMKTS:BNXTF – Get Free Report)’s share price traded up 23.1% during trading on Friday. The stock traded as high as $0.2617 and last traded at $0.2617. Approximately 500 shares changed hands during mid-day trading, an increase of 29% from the average session volume of 388 shares. The stock had previously closed at $0.2126.

BioNxt Solutions Stock Performance

The firm’s 50-day moving average price is $0.25 and its two-hundred day moving average price is $0.28. The firm has a market capitalization of $35.61 million, a price-to-earnings ratio of -5.23 and a beta of 0.70.

BioNxt Solutions (OTCMKTS:BNXTF – Get Free Report) last posted its quarterly earnings data on Friday, August 28th. The company reported ($0.01) earnings per share for the quarter.

BioNxt Solutions Company Profile

(Get Free Report)

BioNxt Solutions Inc is a life sciences company focused on developing drug-delivery and diagnostic technologies. The company’s platform areas include orally dissolvable thin-film formulations, transdermal delivery systems and diagnostic products designed to support more convenient and efficient administration of pharmaceutical treatments.

BioNxt’s development programs have included oral thin-film versions of established pharmaceutical compounds, as well as technologies intended for applications in neurological, infectious-disease and other therapeutic areas.

Read More

Receive News & Ratings for BioNxt Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNxt Solutions and related companies with MarketBeat.com's FREE daily email newsletter.